— SAILE Advisory
Health, wellness and longevity advisory for organisations.
SAILE is the B2B advisory and transformation arm connected to Five Delphi. We help organisations understand whether their proposition is credible, commercially viable, operationally deliverable — and clear enough for customers to trust, use and keep paying for.
— The Challenge
Interest alone does not create a successful proposition.
Health and wellness are now major growth areas for premium brands. But many organisations invest in the space, the brand, the equipment and the partners before fully testing whether the model will convert, retain customers and justify further investment.
SAILE helps answer that question before launch, relaunch, scale or further spend.
— The Flagship Review
The SAILE Health Proposition Diagnostic.
A focused review for organisations that already have, or are planning, a health, wellness or longevity offer — designed for leadership teams who want an external view before investing further.
The output is a clear, leadership-ready report with risks, opportunities, quick wins and recommended next steps.
— Services
Four ways SAILE works with you.
Health Proposition Diagnostic
A confidential, leadership-level pressure-test of an existing or planned health, wellness or longevity proposition before launch, relaunch, scale or further investment.
Explore this service →Wellness Hub & Proposition Strategy
Strategy support for organisations shaping a new premium health, wellness or longevity concept, from the customer promise through to launch planning.
Explore this service →Vendor & Partner Review
An independent review of proposed or existing health and wellness partners to test fit, credibility, delivery risk and contribution to the customer proposition.
Explore this service →Operating Model & Transformation Support
Practical support to turn an agreed health or wellness proposition into a clear, governed and repeatable way of working.
Explore this service →— Who It Is For
Organisations where health, wellness or longevity is becoming part of the customer proposition.
— Common Reasons To Call
The questions leadership teams bring to SAILE.
— Why SAILE
Led by Ola Kotun, founder of Five Delphi.
Ola brings 16 years of experience across clinical practice, NHS and private healthcare, consulting, digital health, operating model design and healthcare transformation — including senior work across Nuffield Health, Cleveland Clinic London and KPMG healthcare advisory.
The focus is not just whether an idea sounds attractive, but whether it can be trusted, delivered, used and scaled.
Why organisations choose SAILE →— Independent By Design
An external pressure-test, nothing else.
- We do not sell equipment.
- We do not take vendor commissions.
- We do not make paid introductions.
- We do not act as a clinical provider.
Our role is to help organisations make better decisions before investing further.
— What Clients Receive
Tangible outputs, ready for the board.
- —Confidential diagnostic report
- —Executive summary for leadership or board review
- —Risk and opportunity register
- —Customer journey review
- —Partner and vendor assessment
- —Commercial and operating model observations
- —30/60/90-day improvement plan
- —Implementation roadmap
- —Follow-on advisory support
— Example Engagement
A typical diagnostic, step by step.
- 01Short scoping call
- 02Review of available materials
- 03Review of the customer or member journey
- 04Interviews with selected team members
- 05Assessment of commercial, operational and credibility risks
- 06Written findings
- 07Leadership readout
- 08Recommended next steps
The process is designed to be focused, practical and low burden for the client team.
See how a SAILE engagement works →— Work With SAILE
Pressure-test your proposition before further investment.
To discuss a confidential diagnostic or advisory engagement, contact Ola Kotun directly.
Advisory note: SAILE provides advisory and transformation support only. It does not provide clinical care, regulated medical advice, medical certification or clinical approval.